Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke-a Single Center Retrospective Study

习秀霞,刘煜敏,高永哲,李华刚

DOI: https://doi.org/10.3760/cma.j.issn.1673-4165.2010.01.003

2010-01-01

Abstract:Objective To assess the clinical efficacy and safety of intravenous recombinant tissue plasminogen activator (rtPA) in the treatment of acute ischemic stroke and to investigate the thrombolytic time window and the related factors affecting the prognosis of thrombolysis. Methods Ninety-four patients with acute ischemic stroke (40 patients in the rtPA group, 54 patients in the control group) were analyzed retrospectively. The National Institute of Health Stroke Scale (NIHSS) was used to assess neurological function at 24 hours after onset. Early neurological improvement was defined as NIHSS improvement ≥4 or the neurological function recovered completely 24 hours after admissioa The patients were assessed by the modified Rankin Scale (mRS), and the clinical efficacy was assessed by the Barthel Index (BI) and MHSS. Good outcome was defined as BI≥95, mRS ≤1 or NIHSS≤1. In addition, the incidence and mortality of the symptomatic intracranial hemorrhage (sICH) were assessed Results The rate of early neurological improvement at 24 hours in the rtPA group was significantly higher than that in the control group (37.5% vs. 13.0%,OR = 3.900; P =0.007). The rate of good outcome at day 14 after admission in the rtPA group was significantly higher than that in the control group (OR =2.654,95% CI 1.089-7.235, P=0.035). The incidence of sICH in the rtPA group during the hospitali2ation was significantly higher than that in the control group (15.00% vs. 1. 85%, P =0.033), however, there was no significant difference in mortality (17.50% vs. 9. 36%, P =0.054). The multivariate regression analysis indicated that the serum glucose≥8 mmol/L, basilar artery occlusion, NIHSS score≥20, and an early sign of infarction on CT were the independent predicting factors for poor outcome; the rate of good outcome of intravenous thrombolysis within 3 h was significantly higher than that in the 4.5 to 6 h thrombolytic group (47.1% vs. 16.7%, P = 0.034). Conclusions Thrombolysis treatment with intravenous rtPA within 6 h after the onset was safe and effective for patients with acute ischemic stroke, in which the efficacy of intravenous thrombolysis was better within 3 h. The serum glucose≥8 mmol/L, basilar artery occlusion, NIHSS score≥20, and an early sign of infarction on CT were the independent predicting factors for poor outcome.